Vivos Inc. Stock Symbol Reverts to RDGL University of Missouri Report Near Completion
July 29, 2019 07:00 ET
|
Vivos Inc.
Richland WA, July 29, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), stock symbol reverts back to RDGL effective with the open of trading on Monday, July 29. As previously disclosed, the D at...
Vivos Inc. Pilot Clinic Completes First IsoPet® Therapy
July 11, 2019 07:00 ET
|
Vivos Inc.
Richland WA, July 11, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Dr. Michelle Meyers, IsoPet® certified veterinarian practicing at Vista Veterinary Hospital, treated their first patient,...
Vivos Inc. Pilot Clinic Completes Their Certification Training
July 09, 2019 07:00 ET
|
Vivos Inc.
Richland WA, July 09, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD) Vivos, Inc. is pleased to announce that Vista Veterinary Hospital has completed its first Isopet® certification training...
Vivos Inc. Enhances its Intellectual Property Protection
July 02, 2019 07:00 ET
|
Vivos Inc.
Richland WA, July 02, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Vivos today announced the filing of a patent application covering key aspects of its technology and propriety...
Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split
June 27, 2019 15:07 ET
|
Vivos Inc.
Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Announces 1-for-8 Reverse Stock Split
June 26, 2019 07:00 ET
|
Vivos Inc.
Richland, WA, June 26, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Summarizes the Health of Canine Therapy Patients Treated with IsoPet
March 04, 2019 07:00 ET
|
Vivos Inc.
Richland WA, March 04, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), provides a summary of the previous update on dogs that have been treated to date in the canine soft tissue sarcoma...
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
December 04, 2018 15:50 ET
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
October 22, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...
Vivos Inc Sets the Stage for the Introduction of IsoPet® (RadioGel™) to the Veterinarian Community
August 02, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) finalizes its plan to introduce IsoPet® to the veterinarian community. IsoPet® was designated as a device by the FDA and the...